<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32967368</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>18</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Genome Wide Analysis Points towards Subtype-Specific Diseases in Different Genetic Forms of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6938</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21186938</ELocationID><Abstract><AbstractText>Amyotropic lateral sclerosis (ALS) is a lethally progressive and irreversible neurodegenerative disease marked by apparent death of motor neurons present in the spinal cord, brain stem and motor cortex. While more and more gene mutants being established for genetic ALS, the vast majority suffer from sporadic ALS (&gt;90%). It has been challenging, thus, to model sporadic ALS which is one reason why the underlying pathophysiology remains elusive and has stalled the development of therapeutic strategies of this progressive motor neuron disease. To further unravel these pathological signaling pathways, human induced pluripotent stem cell (hiPSCs)-derived motor neurons (MNs) from FUS- and SOD1 ALS patients and healthy controls were systematically compared to independent published datasets. Here through this study we created a gene profile of ALS by analyzing the DEGs, the Kyoto encyclopedia of Genes and Genomes (KEGG) pathways, the interactome and the transcription factor profiles (TF) that would identify altered molecular/functional signatures and their interactions at both transcriptional (mRNAs) and translational levels (hub proteins and TFs). Our findings suggest that FUS and SOD1 may develop from dysregulation in several unique pathways and herpes simplex virus (HSV) infection was among the topmost predominant cellular pathways connected to FUS and not to SOD1. In contrast, SOD1 is mainly characterized by alterations in the metabolic pathways and alterations in the neuroactive-ligand-receptor interactions. This suggests that different genetic ALS forms are singular diseases rather than part of a common spectrum. This is important for patient stratification clearly pointing towards the need for individualized medicine approaches in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dash</LastName><ForeName>Banaja P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0003-4580-139X</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naumann</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies Dresden (CRTD), Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>na</GrantID><Agency>NOMIS Stiftung</Agency><Country/></Grant><Grant><GrantID>VH-VI-510</GrantID><Agency>Helmholtz Virtual Institute "RNA dysmetabolism in ALS and FTD"</Agency><Country/></Grant><Grant><GrantID>na</GrantID><Agency>Hermann und Lilly Schilling-Stiftung f&#xfc;r medizinische Forschung im Stifterverband</Agency><Country/></Grant><Grant><GrantID>na</GrantID><Agency>Else-Kr&#xf6;ner-Fresenius-Stiftung</Agency><Country/></Grant><Grant><GrantID>He2/2</GrantID><Agency>Deutsche Gesellschaft f&#xfc;r Muskelkranke</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006561" MajorTopicYN="N">Herpes Simplex</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="Y">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018139" MajorTopicYN="N">Simplexvirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Kyoto encyclopedia of Genes and Genomes (KEGG)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">differentially expressed genes (DEGs)</Keyword><Keyword MajorTopicYN="N">human induced pluripotent stem cells (iPSC)</Keyword><Keyword MajorTopicYN="N">motorneurons (MN)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32967368</ArticleId><ArticleId IdType="pmc">PMC7555318</ArticleId><ArticleId IdType="doi">10.3390/ijms21186938</ArticleId><ArticleId IdType="pii">ijms21186938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Agosta F., Lunetta C., Filippi M., Quattrini A. Recent advances in amyotrophic lateral sclerosis. J. Neurol. 2016;263:1241&#x2013;1254. doi: 10.1007/s00415-016-8091-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8091-6</ArticleId><ArticleId IdType="pmc">PMC4893385</ArticleId><ArticleId IdType="pubmed">27025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Van Den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:1&#x2013;19. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf3; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in als and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Beleza-Meireles A., Al-Chalabi A. Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives. Amyotroph. Lateral Scler. 2009;10:1&#x2013;14. doi: 10.1080/17482960802585469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802585469</ArticleId><ArticleId IdType="pubmed">19110986</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller K., Brenner D., Weydt P., Meyer T., Grehl T., Petri S., Grosskreutz J., Schuster J., Volk A.E., Borck G., et al. Comprehensive analysis of the mutation spectrum in 301 German ALS families. J. Neurol. Neurosurg. Psychiatry. 2018;89:817&#x2013;827. doi: 10.1136/jnnp-2017-317611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317611</ArticleId><ArticleId IdType="pubmed">29650794</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.C.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011 doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995;38:73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra H., Cordova M., Chen C.S.J., Rajadhyaksha M. Confocal imaging-guided laser ablation of basal cell carcinomas: An ex vivo study. J. Investig. Dermatol. 2015;135:612&#x2013;615. doi: 10.1038/jid.2014.371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2014.371</ArticleId><ArticleId IdType="pmc">PMC4289436</ArticleId><ArticleId IdType="pubmed">25178106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunney P.E., Zink A.N., Holm A.A., Billington C.J., Kotz C.M. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol. Behav. 2017;176:139&#x2013;148. doi: 10.1016/j.physbeh.2017.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2017.03.040</ArticleId><ArticleId IdType="pmc">PMC5510739</ArticleId><ArticleId IdType="pubmed">28363838</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B., Lehmann M., Beaudin M., Nordstr&#xf6;m U., Saikali S., Julien J.P., Gilthorpe J.D., Marklund S.L., Cashman N.R., Andersen P.M., et al. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:1&#x2013;13. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama R.R.K., Ward C.L., Bosco D.A. Functions of FUS/TLS from DNA repair to stress response: Implications for ALS. ASN Neuro. 2014;6 doi: 10.1177/1759091414544472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759091414544472</ArticleId><ArticleId IdType="pmc">PMC4189536</ArticleId><ArticleId IdType="pubmed">25289647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads S.N., Monahan Z.T., Yee D.S., Leung A.Y., Newcombe C.G., O&#x2019;Meally R.N., Cole R.N., Shewmaker F.P. The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Mol. Biol. Cell. 2018;29:1786&#x2013;1797. doi: 10.1091/mbc.E17-12-0735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-12-0735</ArticleId><ArticleId IdType="pmc">PMC6085830</ArticleId><ArticleId IdType="pubmed">29897835</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Macias M.I., Moore D.A.Q., Green R.L., Gomez-Herreros F., Naumann M., Hermann A., Van Damme P., Hafezparast M., Caldecott K.W. FUS (fused in sarcoma) is a component of the cellular response to topoisomerase I&#x2013;induced DNA breakage and transcriptional stress. Life Sci. Alliance. 2019;2:1&#x2013;14. doi: 10.26508/lsa.201800222.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800222</ArticleId><ArticleId IdType="pmc">PMC6391683</ArticleId><ArticleId IdType="pubmed">30808650</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Lehmann R., Broihier H.T., Moore L.A., Lehmann R., Lehmann R., Davey J., Nielsen O., Varshavsky A., Hamon Y., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207&#x2013;210. doi: 10.1093/nar/30.1.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.1.207</ArticleId><ArticleId IdType="pmc">PMC99122</ArticleId><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9 doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsen T., de Vlieg J., Alkema W. BioVenn&#x2014;A web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008;9:1&#x2013;6. doi: 10.1186/1471-2164-9-488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-9-488</ArticleId><ArticleId IdType="pmc">PMC2584113</ArticleId><ArticleId IdType="pubmed">18925949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Feuer R., Cashman N., Luo H. Enteroviral infection: The forgotten link to amyotrophic lateral sclerosis? Front. Mol. Neurosci. 2018;11:1&#x2013;8. doi: 10.3389/fnmol.2018.00063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference><Reference><Citation>Su L.N., Song X.Q., Xue Z.X., Zheng C.Q., Yin H.F., Wei H.P. Network analysis of microRNAs, transcription factors, and target genes involved in axon regeneration. J. Zhejiang Univ. Sci. B. 2018;19:293&#x2013;304. doi: 10.1631/jzus.B1700179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B1700179</ArticleId><ArticleId IdType="pmc">PMC5964340</ArticleId><ArticleId IdType="pubmed">29616505</ArticleId></ArticleIdList></Reference><Reference><Citation>Shastri A., Bonifati D.M., Kishore U. Innate immunity and neuroinflammation. Mediators Inflamm. 2013 doi: 10.1155/2013/342931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/342931</ArticleId><ArticleId IdType="pmc">PMC3697414</ArticleId><ArticleId IdType="pubmed">23843682</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian S., Patel P., Spudich S. Neurological Complications of HIV Infection. Curr. Infect. Dis. Rep. 2017;19:1&#x2013;7. doi: 10.1007/s11908-017-0606-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-017-0606-5</ArticleId><ArticleId IdType="pmc">PMC7456329</ArticleId><ArticleId IdType="pubmed">29164407</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications. Front. Immunol. 2017 doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmken C., Hofmann Y., Schoenen F., Oprea G., Raschke H., Rudnik-Sch&#xf6;neborn S., Zerres K., Wirth B. Evidence for a modifying pathway in SMA discordant families: Reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum. Genet. 2003;114:11&#x2013;21. doi: 10.1007/s00439-003-1025-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-003-1025-2</ArticleId><ArticleId IdType="pubmed">14520560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitler B., Froelich S., Marlen K., Shivak D.A., Yu Q., Li D., Pearl J.R., Miller J.C., Zhang L., Paschon D.E., et al. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington&#x2019;s disease. Nat. Med. 2019;25:1131&#x2013;1142. doi: 10.1038/s41591-019-0478-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0478-3</ArticleId><ArticleId IdType="pubmed">31263285</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J., Gill E.E., Hancock R.E.W. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat. Protoc. 2015;10:823&#x2013;844. doi: 10.1038/nprot.2015.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.052</ArticleId><ArticleId IdType="pubmed">25950236</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers R.M., Stamatoyannopoulos J., Snyder M., Dunham I., Hardison R.C., Bernstein B.E., Gingeras T.R., Kent W.J., Birney E., Wold B., et al. A user&#x2019;s guide to the Encyclopedia of DNA elements (ENCODE) PLoS Biol. 2011;9 doi: 10.1371/journal.pbio.1001046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachmann A., Xu H., Krishnan J., Berger S.I., Mazloom A.R., Ma&#x2019;ayan A. ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010;26:2438&#x2013;2444. doi: 10.1093/bioinformatics/btq466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq466</ArticleId><ArticleId IdType="pmc">PMC2944209</ArticleId><ArticleId IdType="pubmed">20709693</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Fornes O., Stigliani A., Gheorghe M., Castro-Mondragon J.A., Van Der Lee R., Bessy A., Ch&#xe8;neby J., Kulkarni S.R., Tan G., et al. JASPAR 2018: Update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2018;46:D260&#x2013;D266. doi: 10.1093/nar/gkx1126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1126</ArticleId><ArticleId IdType="pmc">PMC5753243</ArticleId><ArticleId IdType="pubmed">29140473</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P., et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui S., Fang M., Ni B., Lu D., Martin B., Maudsley S. Central role of the EGF receptor in neurometabolic aging. Int. J. Endocrinol. 2012;2012 doi: 10.1155/2012/739428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/739428</ArticleId><ArticleId IdType="pmc">PMC3382947</ArticleId><ArticleId IdType="pubmed">22754566</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada C., Villalobo A. Epidermal Growth Factor Receptor in the Adult Brain. Cell Cycle Cent. Nerv. Syst. 2008:265&#x2013;277. doi: 10.1007/978-1-59745-021-8_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-59745-021-8_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira A.L., Gomes M., Medeiros R. EGFR signaling pathway and related-miRNAs in age-related diseases: The example of miR-221 and miR-222. Front. Genet. 2012;3:1&#x2013;6. doi: 10.3389/fgene.2012.00286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2012.00286</ArticleId><ArticleId IdType="pmc">PMC3516830</ArticleId><ArticleId IdType="pubmed">23233863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y., Kim S., Varkey J., Lou X., Song J.K., Diao J., Langen R., Shin Y.K. Nonaggregated &#x3b1;-synuclein influences snare-dependent vesicle docking via membrane binding. Biochemistry. 2014;53:3889&#x2013;3896. doi: 10.1021/bi5002536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi5002536</ArticleId><ArticleId IdType="pmc">PMC4075992</ArticleId><ArticleId IdType="pubmed">24884175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibilia M., Steinbach J.P., Stingl L., Aguzzi A., Wagner E.F. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J. 1998;17:719&#x2013;731. doi: 10.1093/emboj/17.3.719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.3.719</ArticleId><ArticleId IdType="pmc">PMC1170421</ArticleId><ArticleId IdType="pubmed">9450997</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Bullock M.R., Altememi N., Zhou Z., Hagood S., Rolfe A., McGinn M.J., Hamm R., Colello R.J. The effect of epidermal growth factor in the injured brain after trauma in rats. J. Neurotrauma. 2010;27:923&#x2013;938. doi: 10.1089/neu.2009.1209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2009.1209</ArticleId><ArticleId IdType="pmc">PMC2943945</ArticleId><ArticleId IdType="pubmed">20158379</ArticleId></ArticleIdList></Reference><Reference><Citation>Offen D., Barhum Y., Melamed E., Embacher N., Schindler C., Ransmayr G. Spinal cord mRNA profile in patients with ALS: Comparison with transgenic mice expressing the human SOD-1 mutant. J. Mol. Neurosci. 2009;38:85&#x2013;93. doi: 10.1007/s12031-007-9004-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-007-9004-z</ArticleId><ArticleId IdType="pubmed">18651250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann J., Monette A., Tripathy V., S&#xf3;jka A., Abo-Rady M., Janosh A., Bhatnagar R., Bickle M., Mouland A.J., Sterneckert J. Viral Infections Exacerbate FUS-ALS Phenotypes in iPSC-Derived Spinal Neurons in a Virus Species-Specific Manner. Front. Cell. Neurosci. 2019;13:1&#x2013;18. doi: 10.3389/fncel.2019.00480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00480</ArticleId><ArticleId IdType="pmc">PMC6817715</ArticleId><ArticleId IdType="pubmed">31695598</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Park H.S., Hong S., Kang S. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS. Exp. Mol. Med. 2016;48:e276. doi: 10.1038/emm.2016.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2016.113</ArticleId><ArticleId IdType="pmc">PMC5192071</ArticleId><ArticleId IdType="pubmed">27932790</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Lee M., Henderson L., Tyagi R., Bachani M., Steiner J., Campanac E., Hoffman D.A., von Geldern G., Johnson K., et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 2015;7:307ra153. doi: 10.1126/scitranslmed.aac8201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac8201</ArticleId><ArticleId IdType="pmc">PMC6344353</ArticleId><ArticleId IdType="pubmed">26424568</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldron D. An endogenous retrovirus contributes to ALS. Nat. Rev. Microbiol. 2015;13:661. doi: 10.1038/nrmicro3578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cermelli C., Vinceti M., Beretti F., Pietrini V., Nacci G., Pietrosemoli P., Bartoletti A., Guidetti D., Sola P., Bergomi M., et al. Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7. Eur. J. Epidemiol. 2003;18:123&#x2013;127. doi: 10.1023/A:1023067728557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1023067728557</ArticleId><ArticleId IdType="pubmed">12733833</ArticleId></ArticleIdList></Reference><Reference><Citation>Sola P., Bedin R., Casoni F., Barozzi P., Mandrioli J., Merelli E. New insights into the viral theory of amyotrophic lateral sclerosis: Study on the possible role of Kaposi&#x2019;s sarcoma-associated virus/human herpesvirus 8. Eur. Neurol. 2002;47:108&#x2013;112. doi: 10.1159/000047961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000047961</ArticleId><ArticleId IdType="pubmed">11844899</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte L.F., Far&#xed;as M.A., &#xc1;lvarez D.M., Bueno S.M., Riedel C.A., Gonz&#xe1;lez P.A. Herpes simplex virus type 1 infection of the central nervous system: Insights into proposed interrelationships with neurodegenerative disorders. Front. Cell. Neurosci. 2019;13:1&#x2013;23. doi: 10.3389/fncel.2019.00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00046</ArticleId><ArticleId IdType="pmc">PMC6399123</ArticleId><ArticleId IdType="pubmed">30863282</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunker W., Song Y., Zhao Y., Karijolich J. FUS negatively regulates Kaposi&#x2019;s sarcoma-associated herpesvirus gene expression. Viruses. 2018;10:359. doi: 10.3390/v10070359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10070359</ArticleId><ArticleId IdType="pmc">PMC6070805</ArticleId><ArticleId IdType="pubmed">29986386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen L.N., Tyagi R., Li W., Alfahad T., Smith B., Wright M., Singer E.J., Nath A. HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology. 2016;87:1756&#x2013;1762. doi: 10.1212/WNL.0000000000003258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003258</ArticleId><ArticleId IdType="pmc">PMC5089528</ArticleId><ArticleId IdType="pubmed">27664983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehnardt S. Innate immunity and neuroinflammation in the CNS: The role of microglia in toll-like receptor-mediated neuronal injury. Glia. 2010;58:253&#x2013;263. doi: 10.1002/glia.20928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20928</ArticleId><ArticleId IdType="pubmed">19705460</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Zhang T., Wang H., Wang T., Qin M., Bao P., Wang R., Liu Y., Chang H.C., Yan J., et al. Neurodegeneration-associated FUS is a novel regulator of circadian gene expression. Transl. Neurodegener. 2018;7:1&#x2013;11. doi: 10.1186/s40035-018-0131-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0131-y</ArticleId><ArticleId IdType="pmc">PMC6182827</ArticleId><ArticleId IdType="pubmed">30338063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Jiang X., Bao P., Qin M., Xu J. Circadian control of stress granules by oscillating EIF2&#x3b1;. Cell Death Dis. 2019;10 doi: 10.1038/s41419-019-1471-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1471-y</ArticleId><ArticleId IdType="pmc">PMC6399301</ArticleId><ArticleId IdType="pubmed">30833545</ArticleId></ArticleIdList></Reference><Reference><Citation>Celona B., Von Dollen J., Vatsavayai S.C., Kashima R., Johnson J.R., Tang A.A., Hata A., Miller B.L., Huang E.J., Krogan N.J., et al. Suppression of c9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. Elife. 2017;6:1&#x2013;17. doi: 10.7554/eLife.19032.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19032</ArticleId><ArticleId IdType="pmc">PMC5283830</ArticleId><ArticleId IdType="pubmed">28072389</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., G&#xfc;nther R., van der Kooi A.J., Aronica E., H&#xfc;bers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2019;6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Genestine M., Caricati E., Fico A., Richelme S., Hassani H., Sunyach C., Lamballe F., Panzica G.C., Pettmann B., Helmbacher F., et al. Enhanced neuronal Met signalling levels in ALS mice delay disease onset. Cell Death Dis. 2011;2:1&#x2013;13. doi: 10.1038/cddis.2011.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2011.11</ArticleId><ArticleId IdType="pmc">PMC3101808</ArticleId><ArticleId IdType="pubmed">21412276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta Mol. Basis Dis. 2010;1802:396&#x2013;405. doi: 10.1016/j.bbadis.2009.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.12.009</ArticleId><ArticleId IdType="pubmed">20079433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama R.R.K., Fallini C., Gatto R., McKeon J.E., Song Y., Rotunno M.S., Penaranda S., Abdurakhmanov I., Landers J.E., Morfini G., et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci. Rep. 2017;7:1&#x2013;13. doi: 10.1038/s41598-017-00091-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00091-1</ArticleId><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Z., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9&#x2013;18. doi: 10.1038/sj.cr.7290105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7290105</ArticleId><ArticleId IdType="pubmed">11942415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn J.S., Sakowski S.A., Kim B., Rosenberg A.A., Feldman E.L. Induced Motor Neuron Degeneration. Dev. Neurobiol. 2009;69:871&#x2013;884. doi: 10.1002/dneu.20747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20747</ArticleId><ArticleId IdType="pmc">PMC2853013</ArticleId><ArticleId IdType="pubmed">19672955</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank E.M., Figueroa-Romero C., Hinder L.M., Bedi K., Archbold H.C., Li X., Weskamp K., Safren N., Paez-Colasante X., Pacut C., et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9 doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Togashi H., Sakisaka T., Takai Y. Cell adhesion molecules in the central nervous system. Cell Adhes. Migr. 2009;3:29&#x2013;35. doi: 10.4161/cam.3.1.6773.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.3.1.6773</ArticleId><ArticleId IdType="pmc">PMC2675146</ArticleId><ArticleId IdType="pubmed">19372758</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagata M., Sanes J.R., Weiner J.A. Synaptic adhesion molecules. Curr. Opin. Cell Biol. 2003;15:621&#x2013;632. doi: 10.1016/S0955-0674(03)00107-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(03)00107-8</ArticleId><ArticleId IdType="pubmed">14519398</ArticleId></ArticleIdList></Reference><Reference><Citation>Washbourne P., Dityatev A., Scheiffele P., Biederer T., Weiner J.A., Christopherson K.S., El-Husseini A. Cell adhesion molecules in synapse formation. J. Neurosci. 2004;24:9244&#x2013;9249. doi: 10.1523/JNEUROSCI.3339-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3339-04.2004</ArticleId><ArticleId IdType="pmc">PMC6730099</ArticleId><ArticleId IdType="pubmed">15496659</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs K.L., Kalmar B., Rhymes E.R., Fellows A.D., Ahmed M., Whiting P., Davies C.H., Greensmith L., Schiavo G. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS article. Cell Death Dis. 2018;9 doi: 10.1038/s41419-018-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0624-8</ArticleId><ArticleId IdType="pmc">PMC5964181</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatrea M., Floyd R.A., Hensley K. Oxidative stress and neuroinflammation in Alzheimer&#x2019;s disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets. J. Alzheimer Dis. 2004;6:147&#x2013;157. doi: 10.3233/JAD-2004-6206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2004-6206</ArticleId><ArticleId IdType="pubmed">15096698</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbeault M., Helleboid P.Y., Trono D. KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks. Nature. 2017 doi: 10.1038/nature21683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21683</ArticleId><ArticleId IdType="pubmed">28273063</ArticleId></ArticleIdList></Reference><Reference><Citation>Herquel B., Ouararhni K., Khetchoumian K., Ignat M., Teletin M., Mark M., B&#xe9;chade G., Van Dorsselaer A., Sanglier-Cianf&#xe9;rani S., Hamiche A., et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 2011 doi: 10.1073/pnas.1101544108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1101544108</ArticleId><ArticleId IdType="pmc">PMC3100982</ArticleId><ArticleId IdType="pubmed">21531907</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle-Garc&#xed;a D., Qadeer Z.A., McHugh D.S., Ghiraldini F.G., Chowdhury A.H., Hasson D., Dyer M.A., Recillas-Targa F., Bernstein E. ATRX binds to atypical chromatin domains at the 3&#x2032; exons of zinc finger genes to preserve H3K9me3 enrichment. Epigenetics. 2016;11:398&#x2013;414. doi: 10.1080/15592294.2016.1169351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2016.1169351</ArticleId><ArticleId IdType="pmc">PMC4939920</ArticleId><ArticleId IdType="pubmed">27029610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wezyk M., Sp&#xf3;lnicka M., Po&#x15b;piech E., Pep&#x142;o&#x144;ska B., Zbie&#x107;-Piekarska R., Ilkowski J., Styczy&#x144;ska M., Barczak A., Zboch M., Filipek-Gliszczynska A., et al. Hypermethylation of TRIM59 and KLF14 influences cell death signaling in familial Alzheimer&#x2019;s disease. Oxid. Med. Cell. Longev. 2018;2018 doi: 10.1155/2018/6918797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6918797</ArticleId><ArticleId IdType="pmc">PMC5904768</ArticleId><ArticleId IdType="pubmed">29849909</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux M.W.C., Revelli J.P., V&#xe1;zquez-Ve&#x142;ez G.E., Kim J.Y., Craigen E., Gonzales K., Beckinghausen J., Zoghbi H.Y. Depleting trim28 in adult mice is well tolerated and reduces levels of &#x3b1;-synuclein and tau. Elife. 2018;7:1&#x2013;16. doi: 10.7554/eLife.36768.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36768</ArticleId><ArticleId IdType="pmc">PMC5993537</ArticleId><ArticleId IdType="pubmed">29863470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch H. RNA polymerase II pausing and transcriptional regulation of the HSP70 expression. Eur. J. Cell Biol. 2017;96:739&#x2013;745. doi: 10.1016/j.ejcb.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2017.09.003</ArticleId><ArticleId IdType="pubmed">29017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi D.A., J&#xf6;nsson M.E., Bratt&#xe5;s P.L., Jakobsson J. TRIM28 and the control of transposable elements in the brain. Brain Res. 2019;1705:43&#x2013;47. doi: 10.1016/j.brainres.2018.02.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.02.043</ArticleId><ArticleId IdType="pubmed">29522722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun R., Liang D., Gao Y., Lan K. Kaposi&#x2019;s Sarcoma-Associated Herpesvirus-Encoded LANA Interacts with Host KAP1 To Facilitate Establishment of Viral Latency. J. Virol. 2014;88:7331&#x2013;7344. doi: 10.1128/JVI.00596-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00596-14</ArticleId><ArticleId IdType="pmc">PMC4054432</ArticleId><ArticleId IdType="pubmed">24741090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien H.C., Wang H.Y., Su Y.N., Lai K.Y., Lu L.C., Chen P.C., Tsai S.F., Wu C.I., Hsieh W.S., Shen C.K.J. Targeted Disruption in Mice of a Neural Stem Cell-Maintaining, KRAB-Zn Finger-Encoding Gene That Has Rapidly Evolved in the Human Lineage. PLoS ONE. 2012;7 doi: 10.1371/journal.pone.0047481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0047481</ArticleId><ArticleId IdType="pmc">PMC3468564</ArticleId><ArticleId IdType="pubmed">23071813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonchev A.B., Yamashima T. &#x201c;Transcribing&#x201d; postischemic neurogenesis: A tale revealing hopes of adult brain repair. J. Mol. Med. 2007;85:539&#x2013;542. doi: 10.1007/s00109-007-0210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-007-0210-5</ArticleId><ArticleId IdType="pubmed">17522833</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh I., Blackmore M.G. Selecting optimal combinations of transcription factors to promote axon regeneration: Why mechanisms matter. Neurosci. Lett. 2017;652:64&#x2013;73. doi: 10.1016/j.neulet.2016.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.12.032</ArticleId><ArticleId IdType="pmc">PMC5466899</ArticleId><ArticleId IdType="pubmed">28025113</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.R., Islam T., Zaman T., Shahjaman M., Karim M.R., Huq F., Quinn J.M.W., Holsinger R.M.D., Gov E., Moni M.A. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer&#x2019;s disease: Insights from a systems biomedicine perspective. Genomics. 2020;112:1290&#x2013;1299. doi: 10.1016/j.ygeno.2019.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2019.07.018</ArticleId><ArticleId IdType="pubmed">31377428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaei M. Peroxisome proliferator-activated receptor-&#x3b3; in amyotrophic lateral sclerosis and Huntington&#x2019;s disease. PPAR Res. 2008;2008 doi: 10.1155/2008/418765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2008/418765</ArticleId><ArticleId IdType="pmc">PMC2366134</ArticleId><ArticleId IdType="pubmed">18464922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter R., Bing G. Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease. Curr. Neuropharmacol. 2007;5:35&#x2013;46. doi: 10.2174/157015907780077123.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015907780077123</ArticleId><ArticleId IdType="pmc">PMC2435341</ArticleId><ArticleId IdType="pubmed">18615152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Haim L., Ceyz&#xe9;riat K., de Sauvage M.A.C., Aubry F., Auregan G., Guillermier M., Ruiz M., Petit F., Houitte D., Faivre E., et al. The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer&#x2019;s and Huntington&#x2019;s diseases. J. Neurosci. 2015;35:2817&#x2013;2829. doi: 10.1523/JNEUROSCI.3516-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3516-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605603</ArticleId><ArticleId IdType="pubmed">25673868</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.-C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng T., Huang Y., Weng K., Lin S., Li Y., Shi G., Chen Y., Huang J., Liu D., Ma W., et al. TOE1 acts as a 3&#x2032; exonuclease for telomerase RNA and regulates telomere maintenance. Nucleic Acids Res. 2019;47:391&#x2013;405. doi: 10.1093/nar/gky1019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1019</ArticleId><ArticleId IdType="pmc">PMC6326811</ArticleId><ArticleId IdType="pubmed">30371886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tz B., Reimann J., Dumitrescu-Ozimek L., Kappes-Horn K., Landreth G.E., Sch&#xfc;rmann B., Zimmer A., Heneka M.T. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J. Neurosci. 2005;25:7805&#x2013;7812. doi: 10.1523/JNEUROSCI.2038-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2038-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725264</ArticleId><ArticleId IdType="pubmed">16120782</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Albertz J., Guo Z., Peng Q., Rudow G., Troncoso J.C., Ross C.A., Duan W. Neuroprotective effects of PPAR-&#x3b3; agonist rosiglitazone in N171-82Q mouse model of Huntington&#x2019;s disease. J. Neurochem. 2013 doi: 10.1111/jnc.12190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12190</ArticleId><ArticleId IdType="pmc">PMC3642978</ArticleId><ArticleId IdType="pubmed">23373812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig S., Kong G., Mannen T., Sadowska A., Kobelke S., Blythe A., Knott G.J., Iyer S.S., Ho D., Newcombe E.A., et al. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. J. Cell Biol. 2015;210:529&#x2013;539. doi: 10.1083/jcb.201504117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504117</ArticleId><ArticleId IdType="pmc">PMC4539981</ArticleId><ArticleId IdType="pubmed">26283796</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A., Maldonado M.A., Bokov A.F., Majumder S., Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2010;107:22687&#x2013;22692. doi: 10.1073/pnas.1012851108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1012851108</ArticleId><ArticleId IdType="pmc">PMC3012497</ArticleId><ArticleId IdType="pubmed">21149712</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000;14:1553&#x2013;1577. doi: 10.1101/gad.14.13.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.14.13.1553</ArticleId><ArticleId IdType="pubmed">10887150</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M., Ko S.Y., Lee I.Y., Wang S.E., Lee S.H., Oh D.H., Kim Y.S., Son H. Carbamylated erythropoietin promotes neurite outgrowth and neuronal spine formation in association with CBP/p300. Biochem. Biophys. Res. Commun. 2014;446:79&#x2013;84. doi: 10.1016/j.bbrc.2014.02.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.02.066</ArticleId><ArticleId IdType="pubmed">24607903</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Glatza M., Hemmer K., Tsytsyura Y., Thiel C.S., H&#xf6;ing S., Moritz S., Parga J.A., Wagner L., Bruder J.M., et al. Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling. PLoS ONE. 2013;8 doi: 10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e</ArticleId><ArticleId IdType="pmc">PMC3606479</ArticleId><ArticleId IdType="pubmed">23533608</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Schmid B., Burbulla L.F., Sch&#xf6;ndorf D.C., Wagner L., Glatza M., H&#xf6;ing S., Hargus G., Heck S.A., Dhingra A., et al. Genetic correction of a lrrk2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013;12:354&#x2013;367. doi: 10.1016/j.stem.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.01.008</ArticleId><ArticleId IdType="pubmed">23472874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursch F., Kalmbach N., Naujock M., Staege S., Eggenschwiler R., Abo-Rady M., Japtok J., Guo W., Hensel N., Reinhardt P., et al. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Hum. Mol. Genet. 2019;28:2835&#x2013;2850. doi: 10.1093/hmg/ddz107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz107</ArticleId><ArticleId IdType="pubmed">31108504</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M., Stanslowsky N., Bufler S., Naumann M., Reinhardt P., Sterneckert J., Kefalakes E., Kassebaum C., Bursch F., Lojewski X., et al. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced. Stem Cells. 2016;34:1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Sel. Work. Terry Speed. 2012:601&#x2013;616. doi: 10.1093/biostatistics/4.2.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/4.2.249</ArticleId><ArticleId IdType="pubmed">12925520</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveros J.C. Venny. An Interactive Tool for Comparing Lists with Venn&#x2019;s Diagrams.  [(accessed on 15 July 2020)];2007  Available online:  https://bioinfogp.cnb.csic.es/tools/venny/index.html.</Citation></Reference><Reference><Citation>Kanehisa M., Sato Y., Kawashima M., Furumichi M., Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457&#x2013;D462. doi: 10.1093/nar/gkv1070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1070</ArticleId><ArticleId IdType="pmc">PMC4702792</ArticleId><ArticleId IdType="pubmed">26476454</ArticleId></ArticleIdList></Reference><Reference><Citation>Broh&#xe9;e S., van Helden J. Evaluation of clustering algorithms for protein-protein interaction networks. BMC Bioinform. 2006;7 doi: 10.1186/1471-2105-7-488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-7-488</ArticleId><ArticleId IdType="pmc">PMC1637120</ArticleId><ArticleId IdType="pubmed">17087821</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>